Penile Cancer: Squamous Penile Cancer: Difference between revisions

Line 387: Line 387:
*# '''Absence of pelvic nodal metastases (pN3)'''
*# '''Absence of pelvic nodal metastases (pN3)'''
*## '''i.e. pN1, and lack of features associated with pN2 and pN3'''
*## '''i.e. pN1, and lack of features associated with pN2 and pN3'''
* '''Indications for pelvic lymph node dissection in patients indergoing inguinal lymph node dissection for curative intent (no pelvic adenopathy):'''
* '''<span style="color:#ff0000">Indications for pelvic lymph node dissection in patients undergoing inguinal lymph node dissection for curative intent (no pelvic adenopathy):</span>'''
*# '''≥2 positive inguinal lymph nodes'''
*# '''<span style="color:#ff0000">≥2 positive inguinal lymph nodes</span>'''
*# '''Extra-nodal extension is present'''
*# '''<span style="color:#ff0000">Extra-nodal extension is present</span>'''
*## '''PLND in this setting serves as staging tool to identify patients who should be considered for adjunctive therapy'''
*## '''PLND in this setting serves as staging tool to identify patients who should be considered for adjunctive therapy'''
*## '''PLND includes the distal common iliac, external iliac, and obturator groups of nodes.'''
*## '''PLND includes the distal common iliac, external iliac, and obturator groups of nodes.'''